Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis
Author(s) -
Valentina Cocciolone,
Katia Cannita,
Maria Letizia Calandrella,
Enrico Ricevuto,
Paola Lanfiuti Baldi,
Tina Sidoni,
Azzurra Irelli,
Stefania Paradisi,
Laura Pizzorno,
V Resta,
Alberto Bafile,
Edoardo Alesse,
Alessandra Tessitore,
Corrado Ficorella
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.18526
Subject(s) - medicine , breast cancer , oncology , cancer , gynecology
To quantify the effect of traditional prognostic factors [nodal status, estrogen-receptor (ER), progesterone-receptor (PR), human epidermal growth factor receptor 2 (HER2)] on long-term outcome of patients with early breast cancer (EBC), treated in clinical practice over a period of about twenty years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom